A research team from the Department of Bioscience, Faculty of Life Sciences, Okayama University of Science, has made a ...
Cancer immunotherapy, especially using T cells, is showing a lot of promise in treating blood cancers. Bioengineered T cells, ...
News Medical on MSN
Leveraging the power of T cells for more effective and durable cancer immunotherapies
T cells play central roles in the adaptive immune response against cancer. Their functional inactivation is a primary driver of tumor progression, making the reactivation of T cell function a main ...
Cutaneous squamous-cell carcinoma (SCC) is primarily caused by oncogenesis mediated by ultraviolet radiation, and β-human papillomavirus (β-HPV) is believed to be a mere facilitator that is ...
Study sets stage for development of synthetic biosensors with custom-built sensing and responses for basic and translational cell engineering applications.
Recently these monocyte-derived alveolar macrophages, or Mo-AMs, were identified as key drivers of lung fibrosis disease progression. However, the mechanisms of their pro-fibrotic behavior and ...
A collaborative research group has developed a novel therapeutic candidate that may improve the prognosis of severe cutaneous ...
Blockbuster anti-obesity drugs like Ozempic and Wegovy have become household names in the past few years. They work by activating the glucagon-like peptide 1 receptor (GLP-1R) to stimulate insulin ...
Nkarta, Inc. (($NKTX)) announced an update on their ongoing clinical study. Study Overview: Nkarta, Inc. is conducting a Phase 1 study titled ‘A ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results